160 related articles for article (PubMed ID: 36240424)
1. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
[TBL] [Abstract][Full Text] [Related]
2. Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018.
Piezzi V; Gasser M; Atkinson A; Kronenberg A; Vuichard-Gysin D; Harbarth S; Marschall J; Buetti N; ;
Euro Surveill; 2020 Sep; 25(35):. PubMed ID: 32885778
[TBL] [Abstract][Full Text] [Related]
3. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
[TBL] [Abstract][Full Text] [Related]
4. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
5. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522664
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
McBride SJ; Upton A; Roberts SA
Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
[TBL] [Abstract][Full Text] [Related]
7. An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome.
Jafari S; Abdollahi A; Sabahi M; Salehi M; Asadollahi-Amin A; Hasannezhad M; Seifi A
Infect Disord Drug Targets; 2022; 22(2):e170322187568. PubMed ID: 33155917
[TBL] [Abstract][Full Text] [Related]
8. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
[TBL] [Abstract][Full Text] [Related]
9. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2020.
Coombs GW; Daley DA; Yee NWT; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469555
[TBL] [Abstract][Full Text] [Related]
10. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.
Pinholt M; Ostergaard C; Arpi M; Bruun NE; Schønheyder HC; Gradel KO; Søgaard M; Knudsen JD;
Clin Microbiol Infect; 2014 Feb; 20(2):145-51. PubMed ID: 23647880
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
12. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Surveillance Outcome Program (AESOP) Bloodstream Infection Annual Report 2022.
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2023 Nov; 47():. PubMed ID: 37968068
[TBL] [Abstract][Full Text] [Related]
13. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
[TBL] [Abstract][Full Text] [Related]
14. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Surveillance Outcome Program (AESOP).
Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Commun Dis Intell (2018); 2022 Nov; 46():. PubMed ID: 36384434
[TBL] [Abstract][Full Text] [Related]
15. A retrospective observational study on enterococcal bacteraemia and endocarditis at a regional hospital in New South Wales, Australia.
Lwin N; Bannan A
Infect Dis Health; 2020 Nov; 25(4):245-252. PubMed ID: 32561340
[TBL] [Abstract][Full Text] [Related]
16. Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
Friedman G; Stepensky P; Abu Ahmad W; Masarwa R; Temper V; Oster Y; Amit S; Averbuch D
Pediatr Infect Dis J; 2020 Apr; 39(4):318-324. PubMed ID: 31990889
[TBL] [Abstract][Full Text] [Related]
17. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Mainous MR; Lipsett PA; O'Brien M
Arch Surg; 1997 Jan; 132(1):76-81. PubMed ID: 9006556
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India.
Tripathi A; Shukla SK; Singh A; Prasad KN
Indian J Med Microbiol; 2016; 34(1):38-45. PubMed ID: 26776117
[TBL] [Abstract][Full Text] [Related]
19. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
Suzuki H; Hase R; Otsuka Y; Hosokawa N
J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
[TBL] [Abstract][Full Text] [Related]
20. The ongoing challenge of vancomycin-resistant
Ayobami O; Willrich N; Reuss A; Eckmanns T; Markwart R
Emerg Microbes Infect; 2020 Dec; 9(1):1180-1193. PubMed ID: 32498615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
